pre-ipo
Stage
About
BioDlink is a China-based CDMO specializing in the development, process optimization, commercial GMP manufacturing, and regulatory support of biological drugs including monoclonal antibodies and antibody-drug conjugates (ADCs).
Explore BioDlink's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.